Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors
- 29 May 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- p. OP2501048
Abstract
PURPOSE: Patient, tumor, and treatment factors can help predict the chance that a woman with a history of breast cancer diagnosis will be diagnosed with a second breast cancer within a year of a negative mammogram. This qualitative study elucidates breast cancer survivor and multispecialty physician perspectives on barriers/facilitators to clinical implementation of a risk-prediction tool to support surveillance decisions. MATERIALS AND METHODS: We enrolled women who completed primary breast cancer treatment and physicians from November 2023 to April 2024. Participants were recruited through Breast Cancer Surveillance Consortium's registries; patients participated in one of four focus groups and physicians participated in individual semistructured interviews. Participants were presented with information about an interval cancer risk prediction tool and were prompted to share perspectives on facilitators and barriers to using such a tool. To identify salient themes, thematic analysis was undertaken by three research team members. RESULTS: Participants included 40 physicians and 23 patients. Three themes emerged: (1) evidence needed for tool acceptance, (2) tool features to facilitate usage, and (3) barriers to tool adoption. Both cancer survivor and physician groups were accepting of risk prediction tool use for surveillance imaging when tool development information was available; they perceived the tool would fit within workflows, and data integrity could be verified. Both groups anticipated structural (time) and technological barriers (magnetic resonance imaging availability) could impede adoption. CONCLUSION: Qualitative findings from focus groups and interviews analyzed thematically suggest implementing a risk prediction tool for surveillance imaging requires evidence transparency, health record integration, data integrity protection, and system supports to promote ease of use in clinical settings while mitigating unintended consequences. All are important to consider during tool development and implementation planning.Keywords
This publication has 28 references indexed in Scilit:
- Grading and assessment of clinical predictive tools for paediatric head injury: a new evidence-based approachBMC Emergency Medicine, 2019
- A systematic review and quality assessment of individualised breast cancer risk prediction modelsBritish Journal of Cancer, 2019
- Clinical prediction rules: A systematic review of healthcare provider opinions and preferencesInternational Journal of Medical Informatics, 2019
- Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategiesJournal of Surgical Oncology, 2019
- The American Joint Commission Cancer 8th Edition Prognostic Stage Including Oncotype DX® Recurrence Score: Impact on Staging of Early Breast CancerPathobiology, 2018
- Women’s experiences and preferences regarding breast imaging after completing breast cancer treatmentPatient Preference and Adherence, 2017
- Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic reviewJournal of the American Medical Informatics Association, 2016
- Risk prediction tools for cancer in primary careBritish Journal of Cancer, 2015
- Breast cancer specialists’ views on and use of risk prediction models in clinical practice: A mixed methods approachActa Oncologica, 2014
- What can “thematic analysis” offer health and wellbeing researchers?International Journal of Qualitative Studies on Health and Well-being, 2014